May 2, 2018 / 4:46 AM / 3 months ago

BRIEF-India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets

May 2 (Reuters) - Strides Shasun Ltd:

* STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS

* PRODUCT WILL BE MANUFACTURED AT CO’S ORAL DOSAGE FACILITY AT PUDUCHERRY

* PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN THE U.S. MARKET Source text - bit.ly/2re6dw0 Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below